Ambry Genetics Agrees To Pay Roche Diagnostics Royalties Due For Licensing Of PCR Technology

PLEASANTON, Calif.--(BUSINESS WIRE)--Roche Diagnostics today announced that its royalty dispute with Ambry Genetics has been settled. The dispute involved Roche’s Patent Portfolio for Polymerase Chain Reaction (PCR) and related technology.